VEGFA and breast carcinoma: Ławicki et al. [79] evaluated the levels of VEGF, matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in patients diagnosed with breast cancer.